US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist
  • 1.0600
  • +0.0300+2.91%
Close Dec 26 16:00 ET
  • 1.0799
  • +0.0199+1.88%
Post 19:57 ET
133.35MMarket Cap-5.05P/E (TTM)

Atossa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-22.33%-4.75M
-1.48%-4.53M
33.10%-4.7M
-0.87%-20.94M
-23.17%-5.57M
28.23%-3.88M
24.95%-4.47M
-43.95%-7.02M
-26.03%-20.76M
-23.41%-4.52M
Net income from continuing operations
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
22.25%-6.23M
-47.35%-9.83M
-31.24%-6.28M
-30.84%-26.96M
-55.03%-7.49M
Operating gains losses
---1K
--2K
--2K
----
----
----
----
----
--3K
--0
Depreciation and amortization
33.33%4K
33.33%4K
66.67%5K
187.50%23K
600.00%14K
50.00%3K
50.00%3K
50.00%3K
-65.22%8K
0.00%2K
Change In working capital
-98.73%18K
50.85%1.16M
132.63%756K
353.59%1.52M
16.12%1.65M
52.04%1.42M
173.10%769K
-21.95%-2.32M
48.18%-599K
413.00%1.42M
-Change in receivables
----
----
----
125.84%743K
----
----
----
----
175.29%329K
2.92%-133K
-Change in prepaid assets
-105.11%-153K
132.73%903K
116.99%664K
201.15%2.81M
-474.68%-885K
1,420.81%3M
127.13%388K
122.08%306K
-311.42%-2.77M
74.55%-154K
-Change in payables and accrued expense
189.51%414K
-0.25%400K
102.58%69K
-186.58%-2.12M
-99.63%10K
115.54%143K
-72.38%401K
-235.43%-2.67M
432.46%2.44M
86.89%2.71M
-Change in other current assets
104.18%71K
-11,000.00%-111K
--0
-184.25%-1.7M
--0
-223.96%-1.7M
99.88%-1K
100.88%1K
-14.59%-597K
14.78%-992K
-Change in other current liabilities
-1,156.00%-314K
-68.42%-32K
-50.00%23K
89,300.00%1.78M
22,375.00%1.78M
-525.00%-25K
-205.56%-19K
675.00%46K
-111.76%-2K
-366.67%-8K
Cash from discontinued investing activities
Operating cash flow
-22.33%-4.75M
-1.48%-4.53M
33.10%-4.7M
-0.87%-20.94M
-23.17%-5.57M
28.23%-3.88M
24.95%-4.47M
-43.95%-7.02M
-26.03%-20.76M
-23.41%-4.52M
Investing cash flow
Cash flow from continuing investing activities
-900.00%-10K
76.92%-3K
-6K
99.70%-14K
0
99.96%-1K
-13K
0
-52,422.22%-4.73M
-2.01M
Net PPE purchase and sale
-900.00%-10K
76.92%-3K
---6K
48.15%-14K
--0
83.33%-1K
---13K
--0
-200.00%-27K
---8K
Net investment purchase and sale
----
----
----
--0
----
----
----
----
---4.7M
---2M
Cash from discontinued investing activities
Investing cash flow
-900.00%-10K
76.92%-3K
---6K
99.70%-14K
--0
99.96%-1K
---13K
--0
-52,422.22%-4.73M
---2.01M
Financing cash flow
Cash flow from continuing financing activities
0
100K
204K
-1.48M
0
-1.48M
0
0
0
0
Net common stock issuance
----
----
----
---1.48M
--0
----
----
----
--0
--0
Proceeds from stock option exercised by employees
--0
--100K
--204K
----
----
--0
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--100K
--204K
---1.48M
--0
---1.48M
--0
--0
--0
--0
Net cash flow
Beginning cash position
-19.96%79.64M
-19.15%84.07M
-20.21%88.57M
-18.67%111M
-19.86%94.14M
-20.81%99.5M
-20.99%103.98M
-18.67%111M
244.11%136.49M
-16.18%117.48M
Current changes in cash
11.18%-4.76M
0.98%-4.43M
35.92%-4.5M
11.99%-22.43M
14.70%-5.57M
33.97%-5.36M
24.73%-4.48M
-43.57%-7.02M
-126.32%-25.49M
-78.25%-6.53M
End cash Position
-20.46%74.88M
-19.96%79.64M
-19.15%84.07M
-20.21%88.57M
-20.21%88.57M
-19.86%94.14M
-20.81%99.5M
-20.99%103.98M
-18.67%111M
-18.67%111M
Free cash flow
-22.55%-4.76M
-1.25%-4.53M
33.01%-4.7M
-0.81%-20.96M
-22.95%-5.57M
28.29%-3.88M
24.73%-4.48M
-43.57%-7.02M
-26.13%-20.79M
-23.63%-4.53M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -22.33%-4.75M-1.48%-4.53M33.10%-4.7M-0.87%-20.94M-23.17%-5.57M28.23%-3.88M24.95%-4.47M-43.95%-7.02M-26.03%-20.76M-23.41%-4.52M
Net income from continuing operations -16.07%-7.23M38.46%-6.05M6.42%-5.88M-11.62%-30.09M-3.51%-7.75M22.25%-6.23M-47.35%-9.83M-31.24%-6.28M-30.84%-26.96M-55.03%-7.49M
Operating gains losses ---1K--2K--2K----------------------3K--0
Depreciation and amortization 33.33%4K33.33%4K66.67%5K187.50%23K600.00%14K50.00%3K50.00%3K50.00%3K-65.22%8K0.00%2K
Change In working capital -98.73%18K50.85%1.16M132.63%756K353.59%1.52M16.12%1.65M52.04%1.42M173.10%769K-21.95%-2.32M48.18%-599K413.00%1.42M
-Change in receivables ------------125.84%743K----------------175.29%329K2.92%-133K
-Change in prepaid assets -105.11%-153K132.73%903K116.99%664K201.15%2.81M-474.68%-885K1,420.81%3M127.13%388K122.08%306K-311.42%-2.77M74.55%-154K
-Change in payables and accrued expense 189.51%414K-0.25%400K102.58%69K-186.58%-2.12M-99.63%10K115.54%143K-72.38%401K-235.43%-2.67M432.46%2.44M86.89%2.71M
-Change in other current assets 104.18%71K-11,000.00%-111K--0-184.25%-1.7M--0-223.96%-1.7M99.88%-1K100.88%1K-14.59%-597K14.78%-992K
-Change in other current liabilities -1,156.00%-314K-68.42%-32K-50.00%23K89,300.00%1.78M22,375.00%1.78M-525.00%-25K-205.56%-19K675.00%46K-111.76%-2K-366.67%-8K
Cash from discontinued investing activities
Operating cash flow -22.33%-4.75M-1.48%-4.53M33.10%-4.7M-0.87%-20.94M-23.17%-5.57M28.23%-3.88M24.95%-4.47M-43.95%-7.02M-26.03%-20.76M-23.41%-4.52M
Investing cash flow
Cash flow from continuing investing activities -900.00%-10K76.92%-3K-6K99.70%-14K099.96%-1K-13K0-52,422.22%-4.73M-2.01M
Net PPE purchase and sale -900.00%-10K76.92%-3K---6K48.15%-14K--083.33%-1K---13K--0-200.00%-27K---8K
Net investment purchase and sale --------------0-------------------4.7M---2M
Cash from discontinued investing activities
Investing cash flow -900.00%-10K76.92%-3K---6K99.70%-14K--099.96%-1K---13K--0-52,422.22%-4.73M---2.01M
Financing cash flow
Cash flow from continuing financing activities 0100K204K-1.48M0-1.48M0000
Net common stock issuance ---------------1.48M--0--------------0--0
Proceeds from stock option exercised by employees --0--100K--204K----------0--0--0--------
Cash from discontinued financing activities
Financing cash flow --0--100K--204K---1.48M--0---1.48M--0--0--0--0
Net cash flow
Beginning cash position -19.96%79.64M-19.15%84.07M-20.21%88.57M-18.67%111M-19.86%94.14M-20.81%99.5M-20.99%103.98M-18.67%111M244.11%136.49M-16.18%117.48M
Current changes in cash 11.18%-4.76M0.98%-4.43M35.92%-4.5M11.99%-22.43M14.70%-5.57M33.97%-5.36M24.73%-4.48M-43.57%-7.02M-126.32%-25.49M-78.25%-6.53M
End cash Position -20.46%74.88M-19.96%79.64M-19.15%84.07M-20.21%88.57M-20.21%88.57M-19.86%94.14M-20.81%99.5M-20.99%103.98M-18.67%111M-18.67%111M
Free cash flow -22.55%-4.76M-1.25%-4.53M33.01%-4.7M-0.81%-20.96M-22.95%-5.57M28.29%-3.88M24.73%-4.48M-43.57%-7.02M-26.13%-20.79M-23.63%-4.53M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data